Our partners

We could not achieve our successes so far without the support and commitment of our partners:

The Innovation Hubs for Gene Therapies network

The Gene Therapy Innovation and Manufacturing Centre (GTIMC) at the University of Sheffield is part of the Innovation Hubs for Gene Therapies network.  The network is a UK based initiative to advance the clinical development of new genetic treatments through the production of clinical grade vectors, alongside translational support and regulatory advice.

The network also includes the Gene Therapy Vector Facility at King's College London, the Royal Free NHS Foundation Trust, UCL Gene Therapy Hub (London hub) and the Clinical Biotechnology Centre at NHS Blood and Transplant, Filton (Bristol hub). 

Our Partners in Sheffield

As part of the University of Sheffield we partner with Sheffield Teaching Hospitals NHS Trust, Sheffield Children's NHS Foundation Trust and the National Institute for Health Research Sheffield Biomedical Research Centre, providing access to a world-class team in driving experimental science into international clinical trials in order to combat devastating diseases and transform millions of lives.

The Cell and Gene Therapy Catapult

The GTIMC works in collaboration with the Cell and Gene Therapy Catapult, an organisation set up to catalyse and facilitate growth in the cell and gene therapy industry. The Catapult helps research into gene therapies to be safer, more effective, scaleable, and affordable.

ARDAT (Accelerating Research & Development for Advanced Therapies)

The Director of the GTIMC, Professor Mimoun Azzouz, is a coordinator within ARDAT (Accelerating Research & Development for Advanced Therapies), a consortium of 34 international partners from academia and industry. ARDAT's aim is to develop and provide tools that will advance knowledge in the field of viral gene/cell therapy and accelerate the development of new treatments for rare diseases.